Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective study

Annals of Thoracic Medicine

Volumn 2, Issue 2, 2007, Pages 52-57

  Dey, Arindam ^a   Bairy, Indira ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Multidrug resistant organisms; Nosocomial pneumonia; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ACINETOBACTER; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; TERTIARY HEALTH CARE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 34249281663     PISSN: 18171737     EISSN: None     Source Type: Journal    
DOI: 10.4103/1817-1737.32230     Document Type: Article

References (30)

1. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262-8.
2. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113:412-20.
3. Clec'h C, Timsit JF, De Lassence A, Azoulay E, Alberti C, Orgeas MG, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: Influence of disease severity. Intensive Care Med 2004;30:1327-33.
4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
5. Rello J, Ollendorf DA, Oster G, Lionch MV, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-21.
6. Celis R, Torres A, Gatell JM, Almela M, Rodriguez RR, Agusti-VA. Nosocomial pneumonia: A multivariate analysis of risk and prognosis. Chest 1988;93:318-24.
7. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia: new perspectives on an old disease. Chest 1995;108:1S-16S.
8. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, et al. Ventilator-associated pneumonia by Staphylococcus aureus: Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150:1545-9.
9. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-8.
10. Rajasekhar T, Anuradha K, Suhasini T, Lakshmi V. The role of quantitative cultures of non-bronchoscopic samples in ventilator associated pneumonia. Indian J Med Microbiol 2006;24:107-13.
11. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the Management of Adults with Hospital acquired, Ventilator-associated and Healthcare-associated Pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
12. Ruiz M, Torres A, Ewig S, Marcos MA, Alcon A, Lledo R, et al. Noninvasive versus invasive microbial investigation in ventilator associated pneumonia: Evaluation of outcome. Am J Respir Crit Care Med 2000;162:119-25.
13. el-Ebiary, M, Torres A, González J, Bellacasa JP, Garcia C, Anta MT, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of Ventilator Associated Pneumonia. Am Rev Respir Dis 1993;148:1552-7.
14. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121-9.
15. Jourdain B, Novara A, Joly GM, Dombret MC, Calvat S, Trouillet JL, et al. Role of quantitative cultures of endotracheal aspirates in the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995;152:241-6.
16. Wu CL, Yang DI, Wang NY, Kuo HT, Chen PZ. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest 2002;122:662-8.
17. th ed. American society for Microbiology: Washington, D.C: 1999. p. 1563-77.
18. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R. Evaluation of methods for AmpC Beta-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 2005;23:120-4.
19. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of Metallo-ß-Lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002;40:3798-801.
20. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993;19:256-64
21. Artigas AT, Dronda SB, Valles EC, Marco JM, Uson MC, Figueras P, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Crit Care Med 2001;29:304-9.
22. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, et al. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-8.
23. Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987;317:1376-82.
24. Rakshit P, Nagar VS, Deshpande AK. Incidence, clinical outcome and risk stratification of ventilator-associated pneumonia-a prospective cohort study. Indian J Crit Care Med 2005;9:211-6.
25. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 2003;51:347-52.
26. Nordmann P, Poirel L. Emerging carbapenemases in gram-negative aerobes. Clin Microbiol Infect 2002;8:321-31.
27. Gales AC, Jones RN, Forward KR, Linares J, Sader S, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001;32:S104-13.
28. Dore P, Robert R, Grollier G, Rouffineau J, Lanquetot H, Charriere JM, et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am J Respir Crit Care Med 1996;153:1292-8.
29. Krasinski K, Holzman RS, Hanna B, Greco MA, Graff M, Bhogal M. Nosocomial fungal infection during hospital renovation. Infect Control 1985;6:278-82.
30. el-Ebiary M, Torres A, Fabregas N, Bellacasa JP, Gonzalez J, Ramirez J, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. Am J Respir Crit Care Med 1997;156:583-90.